Advertisement

Journal of Neural Transmission

, Volume 120, Issue 4, pp 537–542 | Cite as

Musculoskeletal problems in Parkinson’s disease

  • Young Eun Kim
  • Beom S. JeonEmail author
Neurology and Preclinical Neurological Studies - Review Article

Abstract

Musculoskeletal problems are very common and are an important contributor to poor quality of life in Parkinson’s disease. However, they are under-appreciated, under-evaluated, and under-treated. This paper will address the prevalence of musculoskeletal problems in Parkinson’s disease, and review the clinical characteristics of selected musculoskeletal conditions, such as shoulder problems, low back pain, arthritis, deformity, osteoporosis and fracture. Finally, a variety of treatment modalities for musculoskeletal problems will be reviewed.

Keywords

Musculoskeletal Parkinson disease Low back pain: shoulder pain Osteoporosis Fractures 

Notes

Acknowledgments

J.B.S. is supported by a grant of the Korea Health technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A101273).

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Abou-Raya S, Helmii M, Abou-Raya A (2009) Bone and mineral metabolism in older adults with Parkinson’s disease. Age Ageing 38(6):675–680. doi: 10.1093/ageing/afp137 PubMedCrossRefGoogle Scholar
  2. Andreadou E, Anagnostouli M, Vasdekis V, Kararizou E, Rentzos M, Kontaxis T, Evdokimidis I (2011) The impact of comorbidity and other clinical and sociodemographic factors on health-related quality of life in Greek patients with Parkinson’s disease. Aging Mental Health 15(7):913–921. doi: 10.1080/13607863.2011.569477 PubMedCrossRefGoogle Scholar
  3. Ashour R, Jankovic J (2006) Joint and skeletal deformities in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. Mov Dis Off J Mov Disord Soc 21(11):1856–1863. doi: 10.1002/mds.21058 CrossRefGoogle Scholar
  4. Ashour R, Tintner R, Jankovic J (2005) Striatal deformities of the hand and foot in Parkinson’s disease. Lancet Neurol 4(7):423–431. doi: 10.1016/S1474-4422(05)70119-8 PubMedCrossRefGoogle Scholar
  5. Beiske AG, Loge JH, Ronningen A, Svensson E (2009) Pain in Parkinson’s disease: prevalence and characteristics. Pain 141(1–2):173–177. doi: 10.1016/j.pain.2008.12.004 PubMedCrossRefGoogle Scholar
  6. Bellomo G, Santambrogio L, Fiacconi M, Scarponi AM, Ciuffetti G (1991) Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated Parkinson’s disease. J Neurol 238(1):19–22PubMedCrossRefGoogle Scholar
  7. Bezza A, Ouzzif Z, Naji H, Achemlal L, Mounach A, Nouijai M, Bourazza A, Mossadeq R, El Maghraoui A (2008) Prevalence and risk factors of osteoporosis in patients with Parkinson’s disease. Rheumatol Int 28(12):1205–1209. doi: 10.1007/s00296-008-0632-6 PubMedCrossRefGoogle Scholar
  8. Bissonnette B (1986) Pseudorheumatoid deformity of the feet associated with parkinsonism. J Rheumatol 13(4):825–826PubMedGoogle Scholar
  9. Broen MP, Braaksma MM, Patijn J, Weber WE (2012) Prevalence of pain in Parkinson’s disease: a systematic review using the modified QUADAS tool. Mov Dis Off J Mov Disord Soc. doi: 10.1002/mds.24054 Google Scholar
  10. Broetz D, Eichner M, Gasser T, Weller M, Steinbach JP (2007) Radicular and nonradicular back pain in Parkinson’s disease: a controlled study. Mov Dis Off J Mov Disord Soc 22(6):853–856. doi: 10.1002/mds.21439 CrossRefGoogle Scholar
  11. Chen YY, Cheng PY, Wu SL, Lai CH (2012) Parkinson’s disease and risk of hip fracture: an 8-year follow-up study in Taiwan. Park Relat Disord. doi: 10.1016/j.parkreldis.2012.01.014 Google Scholar
  12. Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, Moretto G, Abbruzzese G, Marchese R, Bonuccelli U, Del Dotto P, Barone P, De Vivo E, Albanese A, Antonini A, Canesi M, Lopiano L, Zibetti M, Nappi G, Martignoni E, Lamberti P, Tinazzi M (2008) Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 65(9):1191–1194. doi: 10.1001/archneurol.2008.2 PubMedCrossRefGoogle Scholar
  13. Di Monaco M, Vallero F, Di Monaco R, Tappero R, Cavanna A (2006) Bone mineral density in hip-fracture patients with Parkinson’s disease: a case-control study. Arch Phys Med Rehabil 87(11):1459–1462. doi: 10.1016/j.apmr.2006.07.265 PubMedCrossRefGoogle Scholar
  14. Di Monaco M, Vallero F, Di Monaco R, Tappero R, Cavanna A (2008) Type of hip fracture in patients with Parkinson disease is associated with femoral bone mineral density. Arch Phys Med Rehabil 89(12):2297–2301. doi: 10.1016/j.apmr.2008.06.016 PubMedCrossRefGoogle Scholar
  15. Dias R, Cutts S, Massoud S (2005) Frozen shoulder. Br Med J 331(7530):1453–1456. doi: 10.1136/bmj.331.7530.1453 CrossRefGoogle Scholar
  16. Dural A, Atay MB, Akbostanci C, Kucukdeveci A (2003) Impairment, disability, and life satisfaction in Parkinson’s disease. Disabil Rehabil 25(7):318–323. doi: 10.1080/0963828021000043761 PubMedCrossRefGoogle Scholar
  17. Duvoisin RC, Marsden CD (1975) Note on the scoliosis of Parkinsonism. J Neurol Neurosurg Psychiatry 38(8):787–793PubMedCrossRefGoogle Scholar
  18. Eng ML, Lyons KE, Pahwa R (2006) Prevalence of bone mineral density screening in Parkinson’s disease clinic outpatients. Mov Dis Off J Mov Disord Soc 21(12):2265–2266. doi: 10.1002/mds.21155 CrossRefGoogle Scholar
  19. Etchepare F, Rozenberg S, Mirault T, Bonnet AM, Lecorre C, Agid Y, Bourgeois P, Fautrel B (2006) Back problems in Parkinson’s disease: an underestimated problem. Jt Bone Spine 73(3):298–302. doi: 10.1016/j.jbspin.2005.05.006 CrossRefGoogle Scholar
  20. Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V (2008) Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 65(10):1348–1352. doi: 10.1001/archneur.65.10.1348 PubMedCrossRefGoogle Scholar
  21. Fink HA, Kuskowski MA, Taylor BC, Schousboe JT, Orwoll ES, Ensrud KE (2008) Association of Parkinson’s disease with accelerated bone loss, fractures and mortality in older men: the Osteoporotic Fractures in Men (MrOS) study. Osteoporos Int 19(9):1277–1282. doi: 10.1007/s00198-008-0584-4 PubMedCrossRefGoogle Scholar
  22. Ford B (2010) Pain in Parkinson’s disease. Mov Dis Off J Mov Disord Soc 25(Suppl 1):S98–S103. doi: 10.1002/mds.22716 CrossRefGoogle Scholar
  23. Gage H, Hendricks A, Zhang S, Kazis L (2003) The relative health related quality of life of veterans with Parkinson’s disease. J Neurol Neurosurg Psychiatry 74(2):163–169PubMedCrossRefGoogle Scholar
  24. Genever RW, Downes TW, Medcalf P (2005) Fracture rates in Parkinson’s disease compared with age- and gender-matched controls: a retrospective cohort study. Age Ageing 34(1):21–24. doi: 10.1093/ageing/afh203 PubMedCrossRefGoogle Scholar
  25. Genty S, Derrey S, Pouplin S, Lefaucheur R, Chastan N, Gerardin E, Maltete D (2011) Pain due to osteoarthritis may impair the early outcome of deep brain stimulation in Parkinson’s disease. Clin Neurol Neurosurg 113(10):864–867. doi: 10.1016/j.clineuro.2011.06.006 PubMedCrossRefGoogle Scholar
  26. Gortvai P (1963) Deformities of the hands and feet in Parkinsonism and their reversibility by operation. J Neurol Neurosurg Psychiatry 26:33–36PubMedCrossRefGoogle Scholar
  27. Grimes JD, Hassan MN, Trent G, Halle D, Armstrong GW (1987) Clinical and radiographic features of scoliosis in Parkinson’s disease. Adv Neurol 45:353–355PubMedGoogle Scholar
  28. Invernizzi M, Carda S, Viscontini GS, Cisari C (2009) Osteoporosis in Parkinson’s disease. Park Relat Disord 15(5):339–346. doi: 10.1016/j.parkreldis.2009.02.009 CrossRefGoogle Scholar
  29. Ishizaki F, Harada T, Katayama S, Abe H, Nakamura S (1993) Bone changes in Parkinson’s disease. No to Shinkei (Brain and Nerve) 45(8):719–724Google Scholar
  30. Johnell O, Melton LJ 3rd, Atkinson EJ, O’Fallon WM, Kurland LT (1992) Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota. Age Ageing 21(1):32–38PubMedCrossRefGoogle Scholar
  31. Kamanli A, Ardicoglu O, Ozgocmen S, Yoldas TK (2008) Bone mineral density in patients with Parkinson’s disease. Aging Clin Exp Res 20(3):277–279PubMedGoogle Scholar
  32. Kao CH, Chen CC, Wang SJ, Chia LG, Yeh SH (1994) Bone mineral density in patients with Parkinson’s disease measured by dual photon absorptiometry. Nucl Med Commun 15(3):173–177PubMedCrossRefGoogle Scholar
  33. Koh SB, Roh JH, Kim JH, Oh K, Kim BJ, Kim GS, Park BK, Kim SJ, Yoon JS (2008) Ultrasonographic findings of shoulder disorders in patients with Parkinson’s disease. Mov Dis Off J Mov Disord Soc 23(12):1772–1776. doi: 10.1002/mds.22191 CrossRefGoogle Scholar
  34. Koller WC, Glatt S, Vetere-Overfield B, Hassanein R (1989) Falls and Parkinson’s disease. Clin Neuropharmacol 12(2):98–105PubMedCrossRefGoogle Scholar
  35. Kryzak TJ, Sperling JW, Schleck CD, Cofield RH (2009) Total shoulder arthroplasty in patients with Parkinson’s disease. J Should Elb Surg/American Shoulder and Elbow Surgeons [et al.] 18(1):96–99. doi: 10.1016/j.jse.2008.07.010 Google Scholar
  36. Kryzak TJ, Sperling JW, Schleck CD, Cofield RH (2010) Hemiarthroplasty for proximal humerus fractures in patients with Parkinson’s disease. Clin Orthop Relat Res 468(7):1817–1821. doi: 10.1007/s11999-010-1353-1 PubMedCrossRefGoogle Scholar
  37. Lee SH, Kim MJ, Kim BJ, Kim SR, Chun S, Kim HK, Ryu JS, Kim GS, Lee MC, Chung SJ, Koh JM (2010) Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson’s disease. Calcif Tissue Int 86(2):132–141. doi: 10.1007/s00223-009-9327-6 PubMedCrossRefGoogle Scholar
  38. Leibson CL, Maraganore DM, Bower JH, Ransom JE, O’Brien PC, Rocca WA (2006) Comorbid conditions associated with Parkinson’s disease: a population-based study. Mov Dis Off J Mov Disord Soc 21(4):446–455. doi: 10.1002/mds.20685 CrossRefGoogle Scholar
  39. Lorefalt B, Ganowiak W, Palhagen S, Toss G, Unosson M, Granerus AK (2004) Factors of importance for weight loss in elderly patients with Parkinson’s disease. Acta Neurol Scand 110(3):180–187. doi: 10.1111/j.1600-0404.2004.00307.x PubMedCrossRefGoogle Scholar
  40. Lorefalt B, Toss G, Granerus AK (2007) Bone mass in elderly patients with Parkinson’s disease. Acta Neurol Scand 116(4):248–254. doi: 10.1111/j.1600-0404.2007.00875.x PubMedCrossRefGoogle Scholar
  41. Madden MB, Hall DA (2010) Shoulder pain in Parkinson’s disease: a case–control study. Mov Dis Off J Mov Disord Soc 25(8):1105–1106. doi: 10.1002/mds.23048 CrossRefGoogle Scholar
  42. Melikoglu MA, Sezer I, Kacar C (2007) Rheumatoid-like hand deformities in Parkinson disease. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 13(4):236–237. doi: 10.1097/RHU.0b013e31812e00ca Google Scholar
  43. Moon SH, Lee HM, Chun HJ, Kang KT, Kim HS, Park JO, Moon ES, Chong HS, Sohn JS, Kim HJ (2011) Surgical outcome of lumbar fusion surgery in patients with Parkinson disease. J Spinal Disord Tech. doi: 10.1097/BSD.0b013e318224a625 Google Scholar
  44. Pickering RM, Grimbergen YA, Rigney U, Ashburn A, Mazibrada G, Wood B, Gray P, Kerr G, Bloem BR (2007) A meta-analysis of six prospective studies of falling in Parkinson’s disease. Mov Dis Off J Mov Disord Soc 22(13):1892–1900. doi: 10.1002/mds.21598 CrossRefGoogle Scholar
  45. Reynolds FW, Petropoulous GC (1965) Hand deformities in parkinsonism. J Chron Dis 18:593–595PubMedCrossRefGoogle Scholar
  46. Riley D, Lang AE, Blair RD, Birnbaum A, Reid B (1989) Frozen shoulder and other shoulder disturbances in Parkinson’s disease. J Neurol Neurosurg Psychiatry 52(1):63–66PubMedCrossRefGoogle Scholar
  47. Rugbjerg K, Friis S, Jorgensen TL, Ritz B, Korbo L, Olsen JH (2010) Risk for Parkinson’s disease among patients with osteoarthritis: a Danish cohort study. Mov Dis Off J Mov Disord Soc 25(14):2355–2360. doi: 10.1002/mds.23274 CrossRefGoogle Scholar
  48. Saarni SI, Harkanen T, Sintonen H, Suvisaari J, Koskinen S, Aromaa A, Lonnqvist J (2006) The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res Int J Qual Life Asp Treat Care Rehabil 15(8):1403–1414. doi: 10.1007/s11136-006-0020-1 CrossRefGoogle Scholar
  49. Sato Y, Kikuyama M, Oizumi K (1997) High prevalence of vitamin D deficiency and reduced bone mass in Parkinson’s disease. Neurology 49(5):1273–1278PubMedCrossRefGoogle Scholar
  50. Sato Y, Manabe S, Kuno H, Oizumi K (1999) Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 66(1):64–68PubMedCrossRefGoogle Scholar
  51. Sato Y, Kaji M, Tsuru T, Oizumi K (2001) Risk factors for hip fracture among elderly patients with Parkinson’s disease. J Neurol Sci 182(2):89–93PubMedCrossRefGoogle Scholar
  52. Sato Y, Honda Y, Kaji M, Asoh T, Hosokawa K, Kondo I, Satoh K (2002a) Amelioration of osteoporosis by menatetrenone in elderly female Parkinson’s disease patients with vitamin D deficiency. Bone 31(1):114–118PubMedCrossRefGoogle Scholar
  53. Sato Y, Kaji M, Tsuru T, Satoh K, Kondo I (2002b) Vitamin K deficiency and osteopenia in vitamin D-deficient elderly women with Parkinson’s disease. Arch Phys Med Rehabil 83(1):86–91PubMedCrossRefGoogle Scholar
  54. Sato Y, Iwamoto J, Kanoko T, Satoh K (2006) Alendronate and vitamin D2 for prevention of hip fracture in Parkinson’s disease: a randomized controlled trial. Mov Dis Off J Mov Disord Soc 21(7):924–929. doi: 10.1002/mds.20825 CrossRefGoogle Scholar
  55. Sato Y, Honda Y, Iwamoto J (2007) Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology 68(12):911–915. doi: 10.1212/01.wnl.0000257089.50476.92 PubMedCrossRefGoogle Scholar
  56. Sato Y, Iwamoto J, Honda Y (2011) Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in Parkinson’s disease. Park Relat Disord 17(1):22–26. doi: 10.1016/j.parkreldis.2010.10.008 CrossRefGoogle Scholar
  57. Schabitz WR, Glatz K, Schuhan C, Sommer C, Berger C, Schwaninger M, Hartmann M, Hilmar Goebel H, Meinck HM (2003) Severe forward flexion of the trunk in Parkinson’s disease: focal myopathy of the paraspinal muscles mimicking camptocormia. Mov Dis Off J Mov Disord Soc 18(4):408–414. doi: 10.1002/mds.10385 CrossRefGoogle Scholar
  58. Schneider JL, Fink HA, Ewing SK, Ensrud KE, Cummings SR (2008) The association of Parkinson’s disease with bone mineral density and fracture in older women. Osteoporos Int 19(7):1093–1097. doi: 10.1007/s00198-008-0583-5 PubMedCrossRefGoogle Scholar
  59. Scott B, Borgman A, Engler H, Johnels B, Aquilonius SM (2000) Gender differences in Parkinson’s disease symptom profile. Acta Neurol Scand 102(1):37–43PubMedCrossRefGoogle Scholar
  60. Silva EG, Viana MA, Quagliato EM (2008) Pain in Parkinson’s disease: analysis of 50 cases in a clinic of movement disorders. Arq Neuropsiquiatr 66(1):26–29PubMedCrossRefGoogle Scholar
  61. Slawek J, Derejko M, Lass P (2003) Camptocormia as a form of dystonia in Parkinson’s disease. Eur J Neurol Off J Eur Fed Neurol Soc 10(1):107–108Google Scholar
  62. Song IU, Kim JS, Lee SB, Ryu SY, An JY, Jeong DS, Kim YI, Lee KS (2009) The relationship between low bone mineral density and Parkinson’s disease in a Korean population. J Clin Neurosci 16(6):807–809. doi: 10.1016/j.jocn.2008.08.027 PubMedCrossRefGoogle Scholar
  63. Stamey W, Davidson A, Jankovic J (2008) Shoulder pain: a presenting symptom of Parkinson disease. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 14(4):253–254. doi: 10.1097/RHU.0b013e3181826d43 Google Scholar
  64. Taggart H, Crawford V (1995) Reduced bone density of the hip in elderly patients with Parkinson’s disease. Age Ageing 24(4):326–328PubMedCrossRefGoogle Scholar
  65. Tinazzi M, Del Vesco C, Fincati E, Ottaviani S, Smania N, Moretto G, Fiaschi A, Martino D, Defazio G (2006) Pain and motor complications in Parkinson’s disease. J Neurol Neurosurg Psychiatry 77(7):822–825. doi: 10.1136/jnnp.2005.079053 PubMedCrossRefGoogle Scholar
  66. Vaserman N (2005) Parkinson’s disease and osteoporosis. Jt Bone Spine 72(6):484–488. doi: 10.1016/j.jbspin.2004.04.012 CrossRefGoogle Scholar
  67. Vestergaard P, Rejnmark L, Mosekilde L (2007) Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcif Tissue Int 81(3):153–161. doi: 10.1007/s00223-007-9065-6 PubMedCrossRefGoogle Scholar
  68. Waxman MJ, Durfee D, Moore M, Morantz RA, Koller W (1990) Nutritional aspects and swallowing function of patients with Parkinson’s disease. Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr 5(5):196–199CrossRefGoogle Scholar
  69. Wood B, Walker R (2005) Osteoporosis in Parkinson’s disease. Mov Dis Off J Mov Disord Soc 20(12):1636–1640. doi: 10.1002/mds.20643 CrossRefGoogle Scholar
  70. Woolf AD (2003) How to assess musculoskeletal conditions. History and physical examination. Best Pract Res Clin Rheumatol 17(3):381–402PubMedCrossRefGoogle Scholar
  71. Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81(9):646–656PubMedGoogle Scholar
  72. Wunderlich S, Csoti I, Reiners K, Gunthner-Lengsfeld T, Schneider C, Becker G, Naumann M (2002) Camptocormia in Parkinson’s disease mimicked by focal myositis of the paraspinal muscles. Mov Dis Off J Mov Disord Soc 17(3):598–600. doi: 10.1002/mds.10110 CrossRefGoogle Scholar
  73. Yamada T, Kachi T, Ando K (1995) Osteoporosis and fractures in Parkinson’s disease. Nihon Ronen Igakkai zasshi Jpn J Geriatr 32(10):637–640CrossRefGoogle Scholar
  74. Yucel A, Kusbeci OY (2010) Magnetic resonance imaging findings of shoulders in Parkinson’s disease. Mov Dis Off J Mov Disord Soc 25(15):2524–2530. doi: 10.1002/mds.23310 CrossRefGoogle Scholar
  75. Yun JY, Jeon BS, Kim HJ, Kim YE, Lee JY, Paek SH (2012) Musculoskeletal problems need more attention in deep brain stimulation for Parkinson’s disease. Neurol Asia (accepted)Google Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  1. 1.Department of Neurology, Movement Disorder CenterSeoul National University HospitalSeoulKorea

Personalised recommendations